采用含红霉素方案成功治疗堪萨斯分枝杆菌肺部感染。
Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin.
作者信息
Guest P J, Britton M G, Grundy H C, Yates M D
机构信息
St Peter's Hospital, Chertsey, Surrey.
出版信息
Thorax. 1988 Jun;43(6):488-9. doi: 10.1136/thx.43.6.488.
Abstract
We report a case in which erythromycin was used in place of rifampicin after a severe reaction to the latter in the treatment of pulmonary Mycobacterium kansasii infection.
摘要
我们报告了一例在治疗堪萨斯分枝杆菌肺部感染时，因对利福平发生严重反应而使用红霉素替代利福平的病例。
相似文献
1
Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin.采用含红霉素方案成功治疗堪萨斯分枝杆菌肺部感染。
Thorax. 1988 Jun;43(6):488-9. doi: 10.1136/thx.43.6.488.
2
Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.堪萨斯分枝杆菌肺部感染：与肺结核的临床特征、治疗及转归比较
Thorax. 1996 Dec;51(12):1248-52. doi: 10.1136/thx.51.12.1248.
3
Cutaneous Mycobacterium kansasii infection--treatment with erythromycin.堪萨斯分枝杆菌皮肤感染——红霉素治疗
Clin Exp Dermatol. 1991 Jul;16(4):300-2. doi: 10.1111/j.1365-2230.1991.tb00382.x.
4
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.1970 - 1979年威尔士堪萨斯分枝杆菌肺部感染：治疗与反应回顾
Thorax. 1983 Apr;38(4):271-4. doi: 10.1136/thx.38.4.271.
5
[Acquired rifampicin resistance during M. kansasii infection in a patient with AIDS].[艾滋病患者堪萨斯分枝杆菌感染期间获得性利福平耐药]
Rev Mal Respir. 1992;9(4):464-6.
6
7
Emergence of multidrug-resistant Mycobacterium fortuitum during treatment.治疗期间出现多重耐药性偶然分枝杆菌。
Chest. 1984 Mar;85(3):440-1. doi: 10.1378/chest.85.3.440.
8
Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.堪萨斯分枝杆菌所致肺部及播散性感染：十年经验总结
Rev Infect Dis. 1990 Sep-Oct;12(5):760-7. doi: 10.1093/clinids/12.5.760.
9
Pulmonary disease in immunocompetent host: Treatment outcomes with short-course chemotherapy.免疫功能正常宿主的肺部疾病：短程化疗的治疗结果
Indian J Med Microbiol. 2016 Oct-Dec;34(4):516-519. doi: 10.4103/0255-0857.195370.
10
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.肺非结核分枝杆菌感染与肺结核患者特征及治疗结果的比较。
Thorax. 1996 Feb;51(2):137-9. doi: 10.1136/thx.51.2.137.
引用本文的文献
1
Preparation and Study of Erythromycin Dry Powder Inhaler Based on Ternary Complex Structure.基于三元复合结构的红霉素干粉吸入剂的制备与研究
AAPS PharmSciTech. 2025 May 30;26(5):151. doi: 10.1208/s12249-025-03140-5.
本文引用的文献
1
Erythromycin in the management of troublesome BCG lesions.红霉素在处理卡介苗接种后棘手病变中的应用
Br J Dis Chest. 1984 Apr;78(2):192-4.
2
Short-course chemotherapy for mycobacteriosis kansasii?堪萨斯分枝杆菌病的短程化疗？
Can Med Assoc J. 1984 Jan 1;130(1):34-8.
3
Erythromycin for BCG cold abscess.用于卡介苗冷脓肿的红霉素。
Lancet. 1984 Oct 27;2(8409):979. doi: 10.1016/s0140-6736(84)91190-5.
4
In-vitro activity of erythromycin against atypical mycobacteria.
J Infect Dis. 1971 Feb;123(2):216-9. doi: 10.1093/infdis/123.2.216.
5
Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination.红霉素与异烟肼治疗卡介苗接种不良反应的比较。
Br Med J (Clin Res Ed). 1985 Mar 30;290(6473):970. doi: 10.1136/bmj.290.6473.970.
6
The nature of mycobacterial disease in south east England, 1977-84.1977 - 1984年英格兰东南部分枝杆菌病的本质
J Epidemiol Community Health. 1986 Dec;40(4):295-300. doi: 10.1136/jech.40.4.295.
7
Infections caused by opportunist mycobacteria: a review.由机会性分枝杆菌引起的感染：综述
J R Soc Med. 1986 Apr;79(4):226-9. doi: 10.1177/014107688607900411.
Zotero 插件